Lipid nanoparticles deliver CRISPR tools directly to lung stem cells, offering new therapeutic avenues for treating genetic ...

Sep. 11, 2024 — A team of doctors and researchers have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never ... Action Plan to Help Patients ...

Sep. 11, 2024 — A team of doctors and researchers have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never ... Pre And Post-Surgical ...

Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua, a wearable ...

SAN ANTONIO, October 16, 2024--bioAffinity VP served on expert panel to update flow cytometry guidelines for unique ...

Erika Diarte-Carr -- who raised over $1 million for her funeral and her children amid her battle with terminal cancer -- has ...

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, making up approximately 80% to 85% of all lung cancer cases. Up to 40% of lung cancer patients develop brain ...

Daiichi Sankyo and AstraZeneca's ENHERTU has been conditionally approved by China's NMPA for a specific type of NSCLC.

Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is ...